Scroll Top
Gain Therapeutics
Gain Therapeutics side image

New Parkinson’s Drug GT-02287 Shows Promising Phase 1b Data

Clinical Trial Vanguard

Oct 08, 2025

New Parkinson’s Drug GT-02287 Shows Promising Phase 1b Data

Latest Articles

Clear Filters
July 1, 2026
Parkinson’s pipeline pushes beyond dopamine
https://www.biocentury.com/article/659501/parkinson-s-pipeline-pushes-beyond-dopamine?utm_term=profiles.biocentury.com
Read More
June 30, 2026
Gain Therapeutics stock surges on FDA clearance for Parkinson’s drug By Investing.com
https://in.investing.com/news/stock-market-news/gain-therapeutics-stock-surges-on-fda-clearance-for-parkinsons-drug-93CH-5475234
Read More
June 11, 2026
Scenic Biotech joins Michael J. Fox LRRK2 consortium with a novel lysosomal bet on Parkinson’s
https://european-biotechnology.com/latest-news/scenic-biotech-joins-michael-j-fox-lrrk2-consortium-with-a-novel-lysosomal-bet-on-parkinsons/
Read More